Anti-Interleukin (IL)-21 Monoclonal Antibody Reduces Disease Severity and Inflammatory Cytokines in Murine Colitis

被引：0
|
作者：
Lewis, Katherine E.
Bilsborough, Janine
Maurer, Mark F.
Bontadelli, Kristen
Waggie, Kim
Krejsa, Cecile M.
Dillon, Stacey R.
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A47 / A48
页数：2
相关论文
共 50 条
  • [31] Anti-inflammatory efficacy of ABX-IL8, a fully human anti-interleukin-8 monoclonal antibody
    Wang, P
    Corvalan, JRF
    Davis, CG
    Yang, XD
    FASEB JOURNAL, 2001, 15 (04): : A362 - A362
  • [32] The effect of anti-interleukin 8 monoclonal antibody on monosodium urate crystals-induced arthritis in rabbit.
    Nishimura, A
    Akahoshi, T
    Takahashi, M
    Takagishi, K
    Itoman, N
    Kondo, H
    Matsushima, K
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 339 - 339
  • [33] CNTO 328, an anti-interleukin (IL)-6 monoclonal antibody (mAb) - Preliminary results of subjects with Castleman's disease from a phase 1 study in selected hematological malignancies.
    VanRhee, Frits
    Fayad, Luis
    Borghaei, Hossein
    Voorhees, Peter M.
    Orlowski, Robert Z.
    Furman, Richard R.
    Zaki, Mohamed
    Prabhakar, Uma
    Jiao, Trina
    Lihou, Christine
    Garay, Carlos A.
    Kurzrock, Razelle
    BLOOD, 2006, 108 (11) : 771A - 772A
  • [34] Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice
    Katsume, A
    Saito, H
    Yamada, Y
    Yorozu, K
    Ueda, O
    Akamatsu, K
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    Ohsugi, Y
    CYTOKINE, 2002, 20 (06) : 304 - 311
  • [35] A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma
    Moreau, P
    Harousseau, JL
    Wijdenes, J
    Morineau, N
    Milpied, N
    Bataille, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) : 661 - 664
  • [36] Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes
    von Herrath, Matthias G.
    Bain, Stephen C.
    Bode, Bruce W.
    Clausen, Jesper Ole
    Coppieters, Ken
    Gaysina, Leylya
    Gumprecht, Janusz
    Hansen, Troels K.
    Mathieu, Chantal
    Portillo, Cristobal Morales
    Mosenzon, Ofri
    Segel, Stine
    Tsoukas, George M.
    Pieber, Thomas
    DIABETES, 2020, 69
  • [37] Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis
    Kanai, T
    Totsuka, T
    Iiyama, R
    Yamazaki, M
    Uraushihara, K
    Nomura, T
    Tezuka, K
    Yagita, H
    Watanabe, M
    GASTROENTEROLOGY, 2002, 122 (04) : A6 - A6
  • [38] EFFECTS OF AN ANTI-INTERLEUKIN-6 (IL-6) MURINE MONOCLONAL-ANTIBODY IN A PATIENT WITH ACUTE MONOBLASTIC LEUKEMIA
    BATAILLE, R
    ZHANG, XG
    WIJDENES, J
    SCHVED, JF
    KLEIN, B
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (04): : 185 - 188
  • [39] Treatment with anti-NAP monoclonal antibody reduces disease severity in murine model of novel angiogenic protein-induced or ovalbumin-induced arthritis
    Nataraj, N. B.
    Krishnamurthy, J.
    Salimath, B. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (02): : 155 - 163
  • [40] Efficacy and safety of anti-interleukin (IL)-21 in combination with liraglutide in adults recently diagnosed with type 1 diabetes
    Mathieu, C.
    von Herrath, M.
    Bain, S. C.
    Bode, B.
    Clausen, J. O.
    Coppieters, K.
    Gaysina, L.
    Gumprecht, J.
    Hansen, T. Krarup
    Morales Portillo, C.
    Mosenzon, O.
    Segel, S.
    Tsoukas, G.
    Pieber, T. R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S25 - S25
12345